[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.

This study has been terminated.

(- Study was terminated due to insufficient clinical efficacy observed in previous studies conducted in postherpetic neuralgia.)

Sponsor:

Information provided by:

Pfizer

ClinicalTrials.gov Identifier:

NCT00348894

First received: July 4, 2006

Last updated: May 31, 2011

Last verified: May 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2007
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)